SONNET BIOTHERAPEUTICS HOLDI (SONN)
US83548R3030 - Common Stock
| TTM (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.46M | -18.83M | -29.72M | -24.98M | -18.47M | |||
| Depreciation Amortization | 16.06K | 12.85K | 10.00K | 10.00K | 1.84M | |||
| Change In Working Capital | -4.54M | -3.12M | 90.00K | 1.09M | -70.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 560.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 110.00K | |||
| Other non cash items | 462.30K | 593.53K | 1.93M | 1.33M | 12.65M | |||
| OPERATING CASH FLOW | -18.51M | -21.34M | -27.69M | -22.55M | -4.05M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -443.25K | -900.00K | 0.00 | -470.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 1.15M | |||
| INVESTING CASH FLOW | N/A | -443.25K | -900.00K | 0.00 | 680.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -750.00 | 0.00 | -20.00K | 0.00 | |||
| Stock Issued/Repurchased | 20.29M | 21.01M | 4.01M | 42.85M | 150.00K | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 3.19M | |||
| FINANCING CASH FLOW | 20.29M | 21.01M | 4.01M | 42.83M | 3.34M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 1.33M | -778.62K | -24.58M | 20.28M | -30.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.51M | -21.34M | -27.69M | -22.55M | -4.05M | |||
| Capital Expenditure | N/A | -443.25K | -900.00K | 0.00 | -470.00K | |||
| FREE CASH FLOW | -18.96M | -21.79M | -28.59M | -22.55M | -4.52M | |||
All data in USD